Drug Information

Drug General Information
Drug ID
D0E2LA
Former ID
DNC001410
Drug Name
TAS-103
Drug Type
Small molecular drug
Indication Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] Phase 1 [546363]
Structure
Download
2D MOL

3D MOL
Formula
C20H21Cl2N3O2
Canonical SMILES
CN(C)CCNC1=C2C(=C3C=CC(=O)C=C3N1)C4=CC=CC=C4C2=O.Cl.Cl
InChI
1S/C20H19N3O2.2ClH/c1-23(2)10-9-21-20-18-17(13-5-3-4-6-14(13)19(18)25)15-8-7-12(24)11-16(15)22-20;;/h3-8,11,21-22H,9-10H2,1-2H3;2*1H
InChIKey
RIVWDXDQMQJOLH-UHFFFAOYSA-N
CAS Number
CAS 174634-09-4
PubChem Compound ID
177284
PubChem Substance ID
12015026, 14806121, 30291664, 33500748, 57395366, 78319566, 104426267, 134340596, 135156111, 163305754, 210274965, 210280603, 227554580, 251971293, 252451390
Target and Pathway
Target(s) DNA topoisomerase II Target Info Modulator
References
Ref 546363Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007714)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.